<?xml version="1.0" encoding="UTF-8"?>
<ref id="B114-biomedicines-08-00060">
 <label>114.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bommareddy</surname>
    <given-names>P.K.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hossain</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kaufman</surname>
    <given-names>H.L.</given-names>
   </name>
  </person-group>
  <article-title>Talimogene laherparepvec (T-VEC) and other oncolytic viruses for the treatment of melanoma</article-title>
  <source>Am. J. Clin. Dermatol.</source>
  <year>2017</year>
  <volume>18</volume>
  <fpage>1</fpage>
  <lpage>15</lpage>
  <pub-id pub-id-type="doi">10.1007/s40257-016-0238-9</pub-id>
  <pub-id pub-id-type="pmid">27988837</pub-id>
 </element-citation>
</ref>
